HealthEquity, Inc. (NASDAQ:HQY) Receives Average Rating of “Moderate Buy” from Analysts

HealthEquity, Inc. (NASDAQ:HQY) has earned an average rating of “Moderate Buy” from the thirteen research firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eleven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $112.20.

A number of research firms have commented on HQY. Royal Bank Of Canada boosted their price target on shares of HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research report on Wednesday, June 3rd. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a research note on Monday, August 31st. Telsey Advisory Group set a $111.00 target price on HealthEquity in a report on Friday, August 28th. Wells Fargo & Company set a $111.00 price target on HealthEquity in a research report on Monday, June 1st. Finally, Citizens Jmp raised their price target on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st.

HealthEquity Stock Performance

HealthEquity stock opened at $88.44 on Tuesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. The stock has a fifty day moving average price of $98.85 and a two-hundred day moving average price of $90.44. HealthEquity has a 52-week low of $72.76 and a 52-week high of $107.62. The firm has a market capitalization of $7.31 billion, a P/E ratio of 31.93, a P/E/G ratio of 1.39 and a beta of 0.22.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.19 by $0.05. The company had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company’s quarterly revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, analysts anticipate that HealthEquity will post 3.93 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Adrian T. Dillon sold 7,632 shares of HealthEquity stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the transaction, the director directly owned 62,395 shares of the company’s stock, valued at $6,527,140.95. The trade was a 10.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Fiore sold 2,470 shares of the company’s stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $95.00, for a total transaction of $234,650.00. Following the transaction, the executive vice president owned 56,643 shares in the company, valued at approximately $5,381,085. This trade represents a 4.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 12,456 shares of company stock worth $1,256,664. Insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of HQY. Tidal Investments LLC increased its stake in shares of HealthEquity by 10.4% in the 2nd quarter. Tidal Investments LLC now owns 42,235 shares of the company’s stock valued at $3,815,000 after buying an additional 3,988 shares during the period. WINTON GROUP Ltd acquired a new position in shares of HealthEquity during the second quarter valued at $4,637,000. Engineers Gate Manager LP boosted its holdings in HealthEquity by 85.9% in the second quarter. Engineers Gate Manager LP now owns 5,271 shares of the company’s stock valued at $476,000 after acquiring an additional 2,436 shares during the last quarter. Integrated Wealth Concepts LLC boosted its holdings in HealthEquity by 3.8% in the second quarter. Integrated Wealth Concepts LLC now owns 14,949 shares of the company’s stock valued at $1,350,000 after acquiring an additional 554 shares during the last quarter. Finally, NewEdge Advisors LLC increased its position in HealthEquity by 34.1% in the second quarter. NewEdge Advisors LLC now owns 17,474 shares of the company’s stock worth $1,578,000 after purchasing an additional 4,447 shares during the period. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services for consumer-directed benefits and healthcare savings accounts. The company helps employers, benefits advisors and individuals manage tax-advantaged accounts, including health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), commuter benefits and other employee benefit programs.

Its offerings include account administration, payment cards, reimbursement services, benefits communication, compliance support, healthcare spending tools and investment options for eligible HSA funds.